Refresh

Saroja Pharma Industries India Ltd. - Research Center

Group () BSE data
Back to Company

Results

Statement

More

Balance Sheet
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund

Equity share capital

2.94 0.23 0.01 0.01

Share application money

- - - -

Preference share capital

- - - -

Reserves & surplus

2.15 3.80 0.93 0.19
Loan funds

Secured loans

10.19 6.14 3.02 1.72

Unsecured loans

- - - -

Total

15.28 10.16 3.95 1.92
Uses of funds
Fixed assets

Gross block

2.35 0.41 0.11 0.06

Less : revaluation reserve

- - - -

Less : accumulated depreciation

0.13 0.07 0.03 -

Net block

2.22 0.34 0.09 0.06

Capital work-in-progress

1.79 - - -

Investments

0.14 0.04 - -
Net current assets

Current assets, loans & advances

17.19 15.13 8.13 4.76

Less : current liabilities & provisions

6.06 5.35 4.27 2.90

Total net current assets

11.13 9.78 3.86 1.86

Miscellaneous expenses not written

- - - -

Total

15.28 10.16 3.95 1.92
Notes:

Book value of unquoted investments

0.14 0.04 - -

Market value of quoted investments

- - - -

Contingent liabilities

- - - -

Number of equity sharesoutstanding (Lacs)

29.36 2.26 0.10 0.10
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com